Early nasal continuous positive airway pressure and necrotizing enterocolitis in preterm infants

Hany Aly, An N. Massaro, Tarek A. Hammad, Sherry Kalla, Jonah Essers

Research output: Contribution to journalArticle

Abstract

BACKGROUND: The use of early nasal continuous positive airway pressure (ENCPAP) as the mode of initial respiratory support for very low birth weight (VLBW) infants has been increasing. The impact of CPAP and oxygen on gut mucosa and perfusion in premature infants is not known. The relation between ENCPAP and necrotizing enterocolitis (NEC) has not been adequately addressed. OBJECTIVE: To evaluate if the use of an individualized respiratory management strategy encouraging the use of ENCPAP is associated with an increased risk of NEC, and to determine risk factors for NEC in premature infants supported by CPAP. METHODS: A retrospective analysis was conducted on VLBW infants (birth weight < 1500 g) managed at 2 institutions that use an ENCPAP respiratory management strategy for premature infants. Data on the use of oxygen and mode of ventilatory support were collected during the first 3 days of life. Diagnosis of NEC was used as the dependent variable in a logistic regression model. Birth weight, gender, prenatal steroid use, mode of respiratory support (CPAP versus ventilator) and fraction of inspired oxygen, umbilical artery catheter placement, partial pressure of oxygen, patent ductus arteriosus, early sepsis, hospital, and delivery room management (ENCPAP versus initial intubation) were controlled for in the model. RESULTS: Data on 343 premature infants were collected for this study. Mean birth weight was 999 ± 289 g and gestational age was 28 ± 2.6 weeks. The majority of patients were managed with ENCPAP, with only 13% of patients intubated in the delivery room. The overall incidence of NEC was 7% (n = 24). The exposure to ENCPAP did not increase the risk for NEC compared with the use of a ventilator. CONCLUSIONS. The risk of NEC in VLBW premature infants was not increased by the use of ENCPAP. Initial respiratory support with ENCPAP seems to be a safe alternative to routine intubation and mechanical ventilation in premature infants.

Original languageEnglish (US)
Pages (from-to)205-210
Number of pages6
JournalPediatrics
Volume124
Issue number1
DOIs
StatePublished - Jul 2009
Externally publishedYes

Fingerprint

Necrotizing Enterocolitis
Continuous Positive Airway Pressure
Premature Infants
Very Low Birth Weight Infant
Birth Weight
Delivery Rooms
Oxygen
Mechanical Ventilators
Intubation
Logistic Models
Umbilical Arteries
Patent Ductus Arteriosus
Partial Pressure
Artificial Respiration
Gestational Age
Sepsis
Mucous Membrane
Catheters
Perfusion
Steroids

Keywords

  • CPAP
  • Delivery room
  • NEC
  • Preterm
  • VLBW infants

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Early nasal continuous positive airway pressure and necrotizing enterocolitis in preterm infants. / Aly, Hany; Massaro, An N.; Hammad, Tarek A.; Kalla, Sherry; Essers, Jonah.

In: Pediatrics, Vol. 124, No. 1, 07.2009, p. 205-210.

Research output: Contribution to journalArticle

Aly, Hany ; Massaro, An N. ; Hammad, Tarek A. ; Kalla, Sherry ; Essers, Jonah. / Early nasal continuous positive airway pressure and necrotizing enterocolitis in preterm infants. In: Pediatrics. 2009 ; Vol. 124, No. 1. pp. 205-210.
@article{bfcdd13592d142a19453e956694ca48f,
title = "Early nasal continuous positive airway pressure and necrotizing enterocolitis in preterm infants",
abstract = "BACKGROUND: The use of early nasal continuous positive airway pressure (ENCPAP) as the mode of initial respiratory support for very low birth weight (VLBW) infants has been increasing. The impact of CPAP and oxygen on gut mucosa and perfusion in premature infants is not known. The relation between ENCPAP and necrotizing enterocolitis (NEC) has not been adequately addressed. OBJECTIVE: To evaluate if the use of an individualized respiratory management strategy encouraging the use of ENCPAP is associated with an increased risk of NEC, and to determine risk factors for NEC in premature infants supported by CPAP. METHODS: A retrospective analysis was conducted on VLBW infants (birth weight < 1500 g) managed at 2 institutions that use an ENCPAP respiratory management strategy for premature infants. Data on the use of oxygen and mode of ventilatory support were collected during the first 3 days of life. Diagnosis of NEC was used as the dependent variable in a logistic regression model. Birth weight, gender, prenatal steroid use, mode of respiratory support (CPAP versus ventilator) and fraction of inspired oxygen, umbilical artery catheter placement, partial pressure of oxygen, patent ductus arteriosus, early sepsis, hospital, and delivery room management (ENCPAP versus initial intubation) were controlled for in the model. RESULTS: Data on 343 premature infants were collected for this study. Mean birth weight was 999 ± 289 g and gestational age was 28 ± 2.6 weeks. The majority of patients were managed with ENCPAP, with only 13{\%} of patients intubated in the delivery room. The overall incidence of NEC was 7{\%} (n = 24). The exposure to ENCPAP did not increase the risk for NEC compared with the use of a ventilator. CONCLUSIONS. The risk of NEC in VLBW premature infants was not increased by the use of ENCPAP. Initial respiratory support with ENCPAP seems to be a safe alternative to routine intubation and mechanical ventilation in premature infants.",
keywords = "CPAP, Delivery room, NEC, Preterm, VLBW infants",
author = "Hany Aly and Massaro, {An N.} and Hammad, {Tarek A.} and Sherry Kalla and Jonah Essers",
year = "2009",
month = "7",
doi = "10.1542/peds.2008-2588",
language = "English (US)",
volume = "124",
pages = "205--210",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Early nasal continuous positive airway pressure and necrotizing enterocolitis in preterm infants

AU - Aly, Hany

AU - Massaro, An N.

AU - Hammad, Tarek A.

AU - Kalla, Sherry

AU - Essers, Jonah

PY - 2009/7

Y1 - 2009/7

N2 - BACKGROUND: The use of early nasal continuous positive airway pressure (ENCPAP) as the mode of initial respiratory support for very low birth weight (VLBW) infants has been increasing. The impact of CPAP and oxygen on gut mucosa and perfusion in premature infants is not known. The relation between ENCPAP and necrotizing enterocolitis (NEC) has not been adequately addressed. OBJECTIVE: To evaluate if the use of an individualized respiratory management strategy encouraging the use of ENCPAP is associated with an increased risk of NEC, and to determine risk factors for NEC in premature infants supported by CPAP. METHODS: A retrospective analysis was conducted on VLBW infants (birth weight < 1500 g) managed at 2 institutions that use an ENCPAP respiratory management strategy for premature infants. Data on the use of oxygen and mode of ventilatory support were collected during the first 3 days of life. Diagnosis of NEC was used as the dependent variable in a logistic regression model. Birth weight, gender, prenatal steroid use, mode of respiratory support (CPAP versus ventilator) and fraction of inspired oxygen, umbilical artery catheter placement, partial pressure of oxygen, patent ductus arteriosus, early sepsis, hospital, and delivery room management (ENCPAP versus initial intubation) were controlled for in the model. RESULTS: Data on 343 premature infants were collected for this study. Mean birth weight was 999 ± 289 g and gestational age was 28 ± 2.6 weeks. The majority of patients were managed with ENCPAP, with only 13% of patients intubated in the delivery room. The overall incidence of NEC was 7% (n = 24). The exposure to ENCPAP did not increase the risk for NEC compared with the use of a ventilator. CONCLUSIONS. The risk of NEC in VLBW premature infants was not increased by the use of ENCPAP. Initial respiratory support with ENCPAP seems to be a safe alternative to routine intubation and mechanical ventilation in premature infants.

AB - BACKGROUND: The use of early nasal continuous positive airway pressure (ENCPAP) as the mode of initial respiratory support for very low birth weight (VLBW) infants has been increasing. The impact of CPAP and oxygen on gut mucosa and perfusion in premature infants is not known. The relation between ENCPAP and necrotizing enterocolitis (NEC) has not been adequately addressed. OBJECTIVE: To evaluate if the use of an individualized respiratory management strategy encouraging the use of ENCPAP is associated with an increased risk of NEC, and to determine risk factors for NEC in premature infants supported by CPAP. METHODS: A retrospective analysis was conducted on VLBW infants (birth weight < 1500 g) managed at 2 institutions that use an ENCPAP respiratory management strategy for premature infants. Data on the use of oxygen and mode of ventilatory support were collected during the first 3 days of life. Diagnosis of NEC was used as the dependent variable in a logistic regression model. Birth weight, gender, prenatal steroid use, mode of respiratory support (CPAP versus ventilator) and fraction of inspired oxygen, umbilical artery catheter placement, partial pressure of oxygen, patent ductus arteriosus, early sepsis, hospital, and delivery room management (ENCPAP versus initial intubation) were controlled for in the model. RESULTS: Data on 343 premature infants were collected for this study. Mean birth weight was 999 ± 289 g and gestational age was 28 ± 2.6 weeks. The majority of patients were managed with ENCPAP, with only 13% of patients intubated in the delivery room. The overall incidence of NEC was 7% (n = 24). The exposure to ENCPAP did not increase the risk for NEC compared with the use of a ventilator. CONCLUSIONS. The risk of NEC in VLBW premature infants was not increased by the use of ENCPAP. Initial respiratory support with ENCPAP seems to be a safe alternative to routine intubation and mechanical ventilation in premature infants.

KW - CPAP

KW - Delivery room

KW - NEC

KW - Preterm

KW - VLBW infants

UR - http://www.scopus.com/inward/record.url?scp=67649608041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649608041&partnerID=8YFLogxK

U2 - 10.1542/peds.2008-2588

DO - 10.1542/peds.2008-2588

M3 - Article

C2 - 19564301

AN - SCOPUS:67649608041

VL - 124

SP - 205

EP - 210

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -